ysis in an RCT of patients with iliofemoral DVT.540
In 209 patients, the absolute risk reduction at 24 months
was 14.4% (0.2%-28%) in PTS reduction, as assessed by Villalta score. However, several occurrences of major bleeding
did occur, offsetting some of the beneﬁt. In properly
selected patients, the beneﬁt of catheter-directed thrombolysis